Physician profile
Sherry J Quick
NPI 1396712899
$1,275.79
in general payments reported to CMS, 2019-2025
18 companies · $174 in 2025
The $174 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $303 · 2022: $214 · 2023: $299 · 2024: $285 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $758.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $217.60 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Corium, LLC | $179.62 | 2021-2024 | Azstarys |
| Pfizer INC. | $128.42 | 2021-2023 | |
| Glaxosmithkline, LLC. | $122.61 | 2022-2025 | Bexsero, Pediarix, Rotarix |
| Tris Pharma INC | $110.52 | 2021-2025 | Onyda Xr |
| Cranial Technologies, INC | $101.82 | 2021-2024 | Doc Band |
| Merck Sharp & Dohme LLC | $83.93 | 2021-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Ironshore Pharmaceuticals INC. | $64.13 | 2024 | |
| Sanofi Pasteur INC. | $60.87 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.37 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $31.91 | 2022-2023 | |
| Supernus Pharmaceuticals, INC. | $28.67 | 2021-2022 | |
| Verrica Pharmaceuticals INC. | $19.86 | 2025 | Ycanth |
| Nestle Healthcare Nutrition INC. | $17.89 | 2021 | |
| Neos Therapeutics, LP | $16.78 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $16.08 | 2025 | Relexxii |
| Collegium Pharmaceutical, INC. | $13.60 | 2025 | Jornay Pm |
| Ultragenyx Pharmaceutical INC. | $12.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherry Quick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.